Business Context and Reporting Period
This Form 8-K was filed by BioRestorative Therapies, Inc. on September 20, 2018, reporting events occurring between September 11, 2018, and September 25, 2018. The filing details unregistered sales of equity securities and the issuance of a new convertible promissory note.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. Specific capital transaction metrics include:
- Debt Conversion: The Company issued 622,898 shares of common stock to settle outstanding indebtedness totaling $623,935 (inclusive of accrued interest and fees).
- New Debt Issuance: On September 14, 2018, the Company issued a convertible promissory note with a principal amount of $105,000.
- Conversion Terms: The new note is convertible at $2.00 per share for the first six months. Thereafter, the conversion price is generally 58% of the fair value of the common stock.
Material Changes
The primary material change reported is the reduction of outstanding indebtedness through an equity swap and the addition of new convertible debt. The filing does not provide comparative financial data against prior periods to quantify changes in liquidity or leverage ratios beyond these specific transactions.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future operations. The transactions were executed under exemptions from registration under Section 4(a)(2) and Section 3(a)(9) of the Securities Act of 1933. The Company relied on the belief that all investors were accredited and had access to material information, including prior 10-K and 10-Q filings.
Investor Verification Checklist
- Verify the impact of the 622,898 share issuance on total outstanding shares and potential dilution.
- Confirm the current fair value of the common stock to assess the potential conversion price (58% discount) for the $105,000 note after the initial six-month period.
- Review the Company's most recent Form 10-Q (ended June 30, 2018) for updated liquidity and cash position following these transactions.
- Assess the total remaining indebtedness after the $623,935 settlement and the addition of the new $105,000 note.